155526-33-3 Usage
Molecular Structure
The compound has a complex molecular structure consisting of an isoindole-dione core with a 2-[3,3-difluoro-6-(2-phenylethoxy)hexyl] side chain.
Fluorine atoms
The compound contains two fluorine atoms (3,3-difluoro) in its structure.
Phenylethoxy group
A phenylethoxy group is attached to the hexyl chain in the compound.
Hexyl chain
The compound has a hexyl chain (six-carbon) as part of its side chain.
Potential pharmaceutical or biochemical relevance
The structure of the compound suggests it may have pharmaceutical or biochemical relevance, possibly as a potential drug or research compound.
Further analysis and research needed
To fully understand and characterize the compound's properties and potential uses, additional analysis and research would be necessary.
Check Digit Verification of cas no
The CAS Registry Mumber 155526-33-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,5,2 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 155526-33:
(8*1)+(7*5)+(6*5)+(5*5)+(4*2)+(3*6)+(2*3)+(1*3)=133
133 % 10 = 3
So 155526-33-3 is a valid CAS Registry Number.
155526-33-3Relevant academic research and scientific papers
7-(2-AMINOETHYL) BENZOTHIAZOLONES
-
, (2008/06/13)
There are disclosed compounds of formula I, Ar--CH. sub.2 CH 2--NH--CR 1 R 2--X--Y I in whichAr represents a group, STR1 X represents a C. sub.1-12 alkylene chain optionally interrupted or terminated by one or more groups selected from--S(O) n--,--O--,--C(Z)--, CR 6 R. sup.7, phenylmethyne,--NR 8--,--CONH--,--NHCO--and--NHCONH--, Y represents an optionally substituted aryl or cycloalkyl group,Z represents O or S, R 1, R 2, R 5 and R 9 each independently represent hydrogen or alkyl C 1-6,R 3 and R 4 represent hydrogen, or R. sup.3 and R 4 together form a group--S--,--NR 9--or--CH 2--,R 6 and R 7 independently represent hydrogen, alkyl C 1-6, fluoro, cyano, or CF. sub.3, provided that at least one of R 6 and R 7 is other than hydrogen,R 8 represents hydrogen or alkyl C 1-6, or when X is interrupted or terminated by more than one--NR 8--group may together with another R 8 group form the chain--CH 2--CH 2--, andn represents 0, 1 or 2,and pharmaceutically acceptable derivatives thereof.Processes for their production and pharmaceutical compositions and methods of treatment involving their use are also described.
